SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: sizzleweed
Search This Board:
Last Post: 10/20/2016 1:02:02 PM - Followers: 447 - Board type: Free - Posts Today: 0

                                     ENTB LATEST NEWS FROM JUNE 1, 2016:






Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328

Web site:


CIK 0001449447

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)

Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.



David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance

 Recent News!

June 1, 2015




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ENTB News: Current Report Filing (8-k) 09/26/2016 06:04:39 AM
ENTB News: Quarterly Report (10-q) 06/20/2016 03:10:17 PM
#37750  Sticky Note sizzleweed 06/25/16 03:12:29 AM
#37795   Excellent. GLTA ronrooster 10/20/16 01:02:02 PM
#37794   Yes I did ctvette2003 10/20/16 12:58:24 PM
#37793   Did u contact transfer agent ?if correct,should move ronrooster 10/20/16 12:17:57 PM
#37792   40,171,083 shares as 10/20/16, increase of 611 LOL ctvette2003 10/20/16 11:31:47 AM
#37791   Great information.Thanks for your post. ronrooster 10/20/16 10:41:00 AM
#37790   Gotinearly, Here is some information from the FDA.GOV website JokersWild12 10/20/16 10:33:22 AM
#37789   What interests me is what are the requirements gotinearly 10/20/16 09:28:24 AM
#37788   As I mentioned in my email below(9/29)NR2F6 is JokersWild12 10/19/16 11:51:34 PM
#37787   ENTB will move fast once the market realizes ronrooster 10/19/16 11:10:42 PM
#37786   ENTB sexy low float offering. 2 bucks a sizzleweed 10/19/16 10:10:04 PM
#37785   As of may 31 o/s 40,170, not what ronrooster 10/19/16 08:00:51 PM
#37784   ENTB any idea of the current share count? sizzleweed 10/19/16 05:10:06 PM
#37783   ENTB awakening as billions of dollars are to sizzleweed 10/19/16 05:08:30 PM
#37782   LOL, every trade is a mirror it gotinearly 10/19/16 12:07:12 PM
#37781   NIce to see Koo's hasn't forgotten about the ctvette2003 10/19/16 09:27:48 AM
#37780   AFT... slb5150 10/19/16 09:17:53 AM
#37779   Entest BioMedical's Zander Therapeutics Unit Files Composition of gotinearly 10/19/16 09:03:31 AM
#37778   Hmmmm. nice action here gotinearly 10/04/16 03:06:50 PM
#37777   Hopefully the animal experiments noted below for NR2F6 JokersWild12 09/29/16 10:39:48 AM
#37776   ENTB. LOAD AND HOLD ANYTHING UNDER A PENNY. sizzleweed 09/27/16 06:15:04 PM
#37775   Keep waiting, Koos has this on mothballs. ctvette2003 09/25/16 04:56:44 PM
#37774   Forgot I had this one. Radio check. Waiting Stowe 09/24/16 06:27:57 PM
#37773   I've had this for a couple years not salesleader 09/23/16 01:54:02 PM
#37772   ENTB MM4U, ENTB will feel the love. It sizzleweed 09/23/16 12:48:47 PM
#37771   Now that's funny as Hell, had to follow salesleader 09/23/16 09:48:00 AM
#37770   ENTB volume building. 2 shares traded today. ENTB sizzleweed 09/22/16 05:51:15 PM
#37769   obligatory reply, hello there salesleader 09/22/16 03:21:24 PM
#37768   ENTB testing testing? anyone there? Our once a sizzleweed 09/22/16 01:32:12 AM
#37767   Regen BioPharma, Inc. Updates Shareholders on Status of Stowe 08/25/16 08:49:18 AM
#37766   Someone is buying ENTB...hmm gotinearly 08/19/16 03:04:03 PM
#37765   Choicetrade won't let me sell ENTB. Anyone know why? gimmekimmy 08/12/16 04:00:00 PM
#37764   Makes coffee in the morning , lights bunson Lockman 08/05/16 11:47:32 AM
#37763   ENTB, what capacity is Christine Ichim filling at ENTB? sizzleweed 07/27/16 01:19:31 PM
#37762   C Ichim just updated LinkedIn profile, still showing jeffshir 07/27/16 01:08:27 AM
#37761   ENTB $66 bucks brings her below a penny. ENTB sizzleweed 07/13/16 11:05:24 PM
#37760   ENTB imo everything happens after the results of sizzleweed 07/10/16 04:39:26 PM
#37759   Does anyone have any indication that ENTB has bucks2pennies 07/05/16 03:37:03 PM
#37758   ENTB good that nobody is mass-selling into the sizzleweed 06/29/16 01:49:02 AM
#37757   Very true. But it is good to gotinearly 06/28/16 08:56:25 PM
#37756   ENTB looks like a pile traded, but it sizzleweed 06/28/16 06:58:08 PM
#37755   ENTB wow that puts the market cap at sizzleweed 06/28/16 06:54:30 PM
#37754   ENTB eventually something will trickle down to the sizzleweed 06/28/16 06:46:06 PM
#37753   65k share bot in 10 minutes gotinearly 06/28/16 03:41:12 PM
#37752   Holy Volume!!! gotinearly 06/28/16 03:27:05 PM
#37751   ENTB 12 BUCKS AND CHANGE TO BRING HER sizzleweed 06/27/16 05:48:50 PM
#37750 sizzleweed 06/25/16 03:12:29 AM
#37749   ENTB rated a buy sizzleweed 06/25/16 03:11:02 AM
#37748   ENTB a solid day, proud of the shareholders sizzleweed 06/25/16 02:57:16 AM
#37747   ENTB until the trials are done and the sizzleweed 06/23/16 01:26:44 AM
#37746   ENTB sexy low float offering. will be trading sizzleweed 06/23/16 01:22:37 AM